Maynard Um
-
-
-
-
-
-
-
Oppenheimer Starts Coherus Biosciences (CHRS) at Outperform
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Misses Q2 EPS by 8c
-
-
-
-
-
-
-
Coherus Biosciences (CHRS) PT Raised to $6 at Baird
-
-
-
-
-
-
-
UBS Downgrades Coherus Biosciences (CHRS) to Neutral
-
-
-
406,847 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

